Status:
COMPLETED
Landiolol in Postoperative Atrial Fibrillation
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Postoperative atrial fibrillation is a common complication after cardiac surgery and is associated with an elevation of morbidity and mortality. The recommended treatment includes heart rate control w...
Eligibility Criteria
Inclusion
- Patient underwent conventional cardiac surgery
- Age \> 18 years
- Writing contentment
Exclusion
- Pre-existing chronic atrial fibrillation
- Contraindication to beta-blockers
- Circulatory shock (cardiac index\<2.2 L/min and lactate\>4mmol/L)
- Distributive shock (cardiac index\>2.2 L/min with norepinephrine dose \> 0.3 µg/kg/min to reach mean arterial pressure \> 65mmHg).
- Acute respiratory distress
- Major bleeding (\>200mL/h)
- Patient already included into an interventional clinical study
- Pregnancy
- No social security insurance
- Patient not able to give consent (curators, patients deprived of public rights)
Key Trial Info
Start Date :
January 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03779178
Start Date
January 17 2019
End Date
December 4 2019
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Louis Pradel
Bron, France